Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy

Pediatric Transplantation

Volumn 10, Issue 1, 2006, Pages 32-37

  Araya, Carlos E ^a   Lew, Judy F ^a   Fennell III, Robert S ^a   Neiberger, Richard E ^a   Dharnidharka, Vikas R ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

BK virus; Cidofovir; Kidney transplant; Nephrotoxicity; Pediatrics

Indexed keywords

BASILIXIMAB; CIDOFOVIR; CREATININE; CYCLOSPORIN A; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROBENECID; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS DNA;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BK VIRUS; CASE REPORT; CHRONIC ALLOGRAFT NEPHROPATHY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DRUG PULSE THERAPY; DRUG TOLERABILITY; EPSTEIN BARR VIRUS; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOPROLIFERATIVE DISEASE; NEPHROTIC SYNDROME; NEPHROTOXICITY; PERITONEAL DIALYSIS; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; BIOPSY; BK VIRUS; CHILD; CYTOSINE; DNA, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; NEPHRITIS, INTERSTITIAL; PHOSPHONIC ACIDS; POLYOMAVIRUS INFECTIONS; PROBENECID; TRANSPLANTATION, HOMOLOGOUS; TUMOR VIRUS INFECTIONS; URICOSURIC AGENTS;

EID: 33646005194     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00391.x     Document Type: Article

References (27)

1. R eploeg MD S torch GA C lifford DB BK virus: a clinical review Clin Infect Dis 2001 33 191 202
2. G ardner SD F ield AM C oleman DV H ulme B New human papovavirus (B.K.) isolated from urine after renal transplantation Lancet 1971 1 1253 1257
3. S hah KV D aniel RW W arszawski RM High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland J Infect Dis 1973 128 784 787
4. B oldorini R V eggiani C B arco D M onga G Kidney and urinary tract polyomavirus infection and distribution: molecular biology investigation of 10 consecutive autopsies Arch Pathol Lab Med 2005 129 69 73
5. C hesters PM H eritage J M c C ance DJ Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues J Infect Dis 1983 147 676 684
6. M engel M M arwedel M R adermacher J et al. Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs Nephrol Dial Transplant 2003 18 1190 1196
7. R amos E D rachenberg CB P apadimitriou JC et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients J Am Soc Nephrol 2002 13 2145 2151
8. D harnidharka VR S tablein DM H armon WE Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS Am J Transplant 2004 4 384 389
9. D e Clercq E Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections Verh K Acad Geneeskd Belg 1996 58 19 47 discussion 47-49
10. C undy KC L i ZH L ee WA Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits Drug Metab Dispos 1996 24 315 321
11. A ndrei G S noeck R V andeputte M D e C lercq E Activities of various compounds against murine and primate polyomaviruses Antimicrob Agents Chemother 1997 41 587 593
12. L alezari JP H olland GN K ramer F et al. Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS J Acquir Immune Defic Syndr Hum Retrovirol 1998 17 339 344
13. K eller LS P eh CA N olan J B annister KM C larkson AR F aull RJ BK transplant nephropathy successfully treated with cidofovir Nephrol Dial Transplant 2003 18 1013 1014
14. L im WH M athew TH C ooper JE B owden S R uss GR Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients Nephrology (Carlton) 2003 8 318 323
15. K adambi PV J osephson MA W illiams J et al. Treatment of refractory BK virus-associated nephropathy with cidofovir Am J Transplant 2003 3 186 191
16. B jorang O T veitan H M idtvedt K B roch LU S cott H A ndresen PA Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient Nephrol Dial Transplant 2002 17 2023 2025
17. V ats A S hapiro R S ingh R andhawa P et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults Transplantation 2003 75 105 112
18. R acusen LC H alloran PF S olez K Banff 2003 meeting report: new diagnostic insights and standards Am J Transplant 2004 4 1562 1566
19. G ardner SD M ac K enzie EF S mith C P orter AA Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients J Clin Pathol 1984 37 578 586
20. T rofe J G aber LW S tratta RJ et al. Polyomavirus in kidney and kidney-pancreas transplant recipients Transpl Infect Dis 2003 5 21 28
21. L i RM M annon RB K leiner D et al. BK virus and SV40 co-infection in polyomavirus nephropathy Transplantation 2002 74 1497 1504
22. S achdeva MS N ada R J ha V S akhuja V J oshi K The high incidence of BK polyoma virus infection among renal transplant recipients in India Transplantation 2004 77 429 431
23. R andhawa PS F inkelstein S S cantlebury V et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney Transplantation 1999 67 103 109
24. H owell DN S mith SR B utterly DW et al. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients Transplantation 1999 68 1279 1288
25. N ickeleit V S ingh HK M ihatsch MJ Polyomavirus nephropathy: morphology, pathophysiology, and clinical management Curr Opin Nephrol Hypertens 2003 12 599 605
26. H o ES L in DC M endel DB C ihlar T Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1 J Am Soc Nephrol 2000 11 383 393
27. P erazella MA Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity Am J Med Sci 2003 325 349 362